Related Experiment Video
Updated: Jul 24, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Management of Stroke in Patients With Chronic Liver Disease: A Practical Review
Neal S Parikh1, Elora Basu, Mu Ji Hwang2
1Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology (N.S.P., E.B., S.B.M., H.K.), Weill Cornell Medicine, New York, NY.
Insights
Chronic liver disease (CLD) significantly impacts stroke risk and outcomes. This review synthesizes current data on CLD
Area of Science:
- Neurology
- Hepatology
- Vascular Medicine
Background:
- Chronic liver disease (CLD) is common and can have subclinical manifestations.
- CLD causes systemic issues like coagulopathy and altered drug metabolism, relevant to stroke.
- Existing stroke guidelines offer limited information on managing patients with CLD.
Purpose of the Study:
- To provide vascular neurologists with a contemporary overview of CLD.
- To review the impact of CLD on stroke risk, mechanisms, and outcomes.
- To discuss acute and chronic treatment strategies for stroke patients with CLD.
Main Methods:
- Multidisciplinary literature review.
- Synthesis of data on CLD and stroke intersection.
- Appraisal of evidence regarding CLD's influence on stroke.
Main Results:
- CLD presents systemic aberrations that affect stroke risk.
- Specific data on CLD's impact on stroke incidence, mechanisms, and prognosis are emerging.
- Treatment considerations for stroke in CLD patients require tailored approaches.
Conclusions:
- CLD is an important factor to consider in stroke patients.
- Further research and guideline development are needed for this population.
- A multidisciplinary approach is crucial for managing stroke in individuals with CLD.
Abstract:
Chronic liver disease (CLD) is a highly prevalent condition. There is burgeoning recognition that there are many people with subclinical liver disease that may nonetheless be clinically significant. CLD has a variety of systemic aberrations relevant to stroke, including thrombocytopenia, coagulopathy, elevated liver enzymes, and altered drug metabolism. There is a growing body of literature on the intersection of CLD and stroke. Despite this, there have been few efforts to synthesize these data, and stroke guidelines provide scant guidance on this topic. To fill this gap, this multidisciplinary review provides a contemporary overview of CLD for the vascular neurologist while appraising data regarding the impact of CLD on stroke risk, mechanisms, and outcomes. Finally, the review addresses acute and chronic treatment considerations for patients with stroke-ischemic and hemorrhagic-and CLD.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Venous Thrombosis IV: Nursing Management
Atherosclerosis III: Management
Chronic Kidney Disease IV: Nursing Management
Chronic Pancreatitis II: Collaborative Care
Assessment:

